IBM is enabling systems of health to become smarter, more efficient and uniquely personalized. We are pioneering a new partnership between humanity and technology with the goal of transforming global health. IBM's healthcare solutions, technology & consulting enable organizations to achieve greater efficiency within their operations, collaborate to improve outcomes, and integrate with new partners for a more sustainable, personalized and patient-centric system.

Find out more - www.ibm.com/industries/healthcare



Aiforia is a first-in-class, versatile cloud-based platform that increases the speed and accuracy of analyzing complex 2-D images. The precise and robust, time-saving platform only requires an internet connection and general domain knowledge to begin training AI-powered models, which can detect subtle changes, remove observer variability and produce quantitative data to help researchers solve some of the most complex problems in pharma today.

Find out more - www.aiforia.com

Concerto HealthAI

Concerto HealthAI, a SymphonyAI portfolio company, is a next generation Real World Evidence company that partners with the American Society of Clinical Oncology’s CancerLinQ initiative and healthcare providers across the U.S. Concerto HealthAI develops engineered Real-World Data products designed for specific use cases, including post approval studies leading to label modifications and market access initiatives and regulatory submissions. Concerto HealthAI’s engineered datasets are deployed in a clinical cloud environment, with AI metadata, AI Models and AI-enabled applications all aligned to generate “precision evidence” required for high priority use cases.

Find out more - www.concertohealthai.com

L7 Informatics

Our mission is to revolutionize scientific process and data management in order to accelerate discoveries and drive higher quality of healthcare. Our end-to-end solutions and services yield efficiencies that enable researchers to make more breakthroughs and healthcare companies to provide superior care.

Find out more - www.l7informatics.com


QuartzBio is a technology driven multiomic data integration and informatics solution. It combines the first platform to successfully integrate diverse biomarker data with AI and computational biology based approaches for insight generation making the complex connections within clinical data ecosystems a reality.

Find out more - www.quartzbio.com



High-quality data is the first step for training Machine-Learning and Artificial Intelligence algorithms, but obtaining this information is difficult as most knowledge about drugs exists within scientific publications in an unstructured text format.

DrugBank data solutions solve this problem by providing detailed, machine-readable information that lets our customers explore AI strategies for drug discovery and repurposing and incorporate extensive scientific knowledge to make their models more powerful.

DrugBank covers approved, investigational, and discovery-stage drugs with detailed descriptions and structured data describing drug-protein relationships, ADMET data, predicted and experimental chemical properties, and clinical information. The data is organized, structured, and connected, making it ideal for experiments in machine learning, feature selection, classification tasks and data analytics.

DrugBank also provides complementary Natural Language Processing solutions to integrate unstructured text with our structured datasets.

Find out more - www.drugbankplus.com


SciBite is an award-winning semantic software company offering an ontology-led approach to transforming unstructured content into machine-readable clean data.

Supporting the top 20 pharma with use cases across life sciences, from comprehensive competitive intelligence monitoring in real time to unlocking the value of your bioassay data or the full potential of ELN data. SciBite empowers customers with a suite of fast, flexible, deployable API technologies, making it a critical component in scientific data-led strategies.

SciBite’s suite of semantic technology is the culmination of the perfect storm of tens of years of experience in unlocking the potential of scientific data to answer business critical questions.

Headquartered in the UK, we support our global customer base through additional sites in the US and Japan. Having received various industry awards including most recently the Queen’s Award for Enterprise in International Trade 2019.

Find out more - www.scibite.com


Speaks Marketing Group

Live events are one of the most reliable ways for companies to connect with their customers. With proper strategy and execution, events offer a plethora of opportunities to brand, educate, and connect directly with the marketplace. At Speaks Marketing, we are dedicated to our clients' missions and work hand-in-hand with teams to bring that mission center stage. From branding and sponsorship opportunities to speaking engagements and 1:1 meeting generation, Speaks will help you design and execute an event plan that is right for you.

Find out more - www.speaksmarketing.com


I made more new contacts at the D4 conference than at any conference over the past couple of years.
— Peter Henstock, Senior Data Scientist, Pfizer

Partnership Opportunities

This meeting is designed specifically to cater for senior people in pharma, combining strategic insights of value to IT/R&D leaders, with technical, evidence-based use-cases and data that attendees can take away to move forwards with confidence and achieve real development in their organizations today and beyond.

Expect audience representation from Roche, Pfizer, Shire, Boehringer Ingelheim, Takenda, Johnson & Johnson, Bayer Healthcare, Janssen, AstraZeneca and many more large and small pharma & biotech companies.

The event will consist of 150-200 senior and C-level delegates (by invitation only).

For more information contact:

Denvor Oorloff, Commercial Manager

T: +44 (0) 208 191 8810 E: denvor@frontlinegenomics.com

Please complete the form below to receive your copy of the sponsorship brochure

A great blend of topics around data-driven drug discovery bringing people from different domains close to each other.
— Martin Romacker, Principal Scientist, Roche